122.4AE178.3 mg/dl, p¼0.006), pre-PCI minimal lumen diameter was smaller (0.19AE0.30mm vs. 0.32AE0.36mm, p¼0.041), pre-PCI diameter stenosis was higher (93.9AE9.5% vs 89.6AE11.5%, p¼0.037), pre PCI TIMI flow was lower (pre-PCI TIMI flow non-3; 77.8% vs. 59.3%, p¼0.038), and post-PCI diameter stenosis was higher (14.6AE5.8% vs. 11.6AE5.0%, p¼0.004). Multivariate analysis revealed peak CK-MB and EF were independent predictor of TP. During three years of follow up, major adverse cardiac events (MACE; target vessel revascularization, myocardial infarction, death) were not different in p¼0.404 Yonsei University College of Medicine, Seoul, Korea, Republic of Background: No randomized studies have been conducted to investigate serial changes of optical coherence tomography (OCT) findings following biolimus-A9-eluting stents (BES) vs. sirolimus-eluting stents (SES) implantation. Methods: A total of 60 patients fulfilling study criteria were randomly assigned into BES (n¼30) and SES (n¼30) implantation. Of these, serial OCT evaluation at postprocedure, 3, and 12 months was performed in 46 patients [BES (n¼22) and SES (n¼24)] and OCT findings were compared according to the types of stents and followed time intervals. The primary endpoint was the percentage of uncovered struts (ratio of uncovered struts to total struts in all cross-sections with 0.2-mm interval) at 3 and 12 months and the changes (D) of percentages between 3-12 months. Results: Although the percentages of uncovered struts at 3 months were not significantly different between two stents, BES compared to SES showed a significantly higher percentage of uncovered struts on 12-month OCT without significant difference of neointimal thickness (See Figure A) . Through serial OCT evaluation, both stents significantly increased strut coverage from 3 to 12 months. However, BES showed a greater D percentage of uncovered struts between 3-12 months than SES (See Figure B) .
Background: No randomized studies have been conducted to investigate serial changes of optical coherence tomography (OCT) findings following biolimus-A9-eluting stents (BES) vs. sirolimus-eluting stents (SES) implantation. Methods: A total of 60 patients fulfilling study criteria were randomly assigned into BES (n¼30) and SES (n¼30) implantation. Of these, serial OCT evaluation at postprocedure, 3, and 12 months was performed in 46 patients [BES (n¼22) and SES (n¼24)] and OCT findings were compared according to the types of stents and followed time intervals. The primary endpoint was the percentage of uncovered struts (ratio of uncovered struts to total struts in all cross-sections with 0.2-mm interval) at 3 and 12 months and the changes (D) of percentages between 3-12 months. Results: Although the percentages of uncovered struts at 3 months were not significantly different between two stents, BES compared to SES showed a significantly higher percentage of uncovered struts on 12-month OCT without significant difference of neointimal thickness (See Figure A) . Through serial OCT evaluation, both stents significantly increased strut coverage from 3 to 12 months. However, BES showed a greater D percentage of uncovered struts between 3-12 months than SES (See Figure B) .
Conclusions:
In this randomized serial OCT study, both DESs still showed the incomplete strut coverage at 3 months but BES compared to SES showed a significantly lower prevalence of uncovered struts at 12 months by superior coverage from 3 to 12 months. Background: Longitudinal stent deformation (LSD) is a recently reported complication of coronary intervention. However, to date, the axial integrity of stents has not been systematically examined. This study aimed to assess the rate of LSD after implantation utilizing intravascular ultrasound (IVUS). Methods: A total of 218 drug-eluting stents (DES) of 197 patients with coronary artery disease who underwent IVUS after implantation for de novo lesions were included: 32.1% sirolimus-eluting stents (SES); 15.6% paclitaxel-eluting stents (PES); 22.9% cobalt-chromium everolimus-eluting stents (CC-EES); and 29.4% platinumchromium everolimus-eluting stents (PC-EES, Element platform). Stent length was determined using automatic pullback of an IVUS catheter. The absolute value of the difference in length [IVUS-measured stent length -labeled stent length] (mm), and the absolute value of the relative difference in length [(IVUS-measured stent lengthlabeled stent length) divided by labeled length] (%) were analyzed. Results: There was no significant difference with regards to the absolute and relative differences in stent length among groups. The absolute relative difference of >5% was the lowest in the SES group compared to the other groups. Significant (>15%) absolute value of the relative difference in stent length was low and similar among groups. (Table) 1 1 Kawasaki medical school, Kurashiki, Japan, 2 Kawasaki hospital, Okayama, Japan Background: Stent underexpansion is still a concern as a cause of drug-eluting stent (DES) failure. Although the amount of coronary calcification is considered as a contributing factor for stent under expansion, a previous intravascular ultrasound (IVUS) study failed to demonstrate relation between stent expansion and coronary calcification. Optical coherence tomography (OCT) offers better quantitative assessment of coronary calcium than IVUS and therefore may have potential to predict stent expansion. Thus, the purpose of this study was to investigate whether stent expansion could be predicted by coronary calcification assessed by OCT. Methods: A total of 51 de novo native coronary artery lesions from 44 patients treated by single 2nd generation DES were enrolled. Prior to stent deployment, arc of calcium and area of calcium at the maximal calcification site within the target lesion were measured using OCT. After successful stent implantation, OCT imaging was repeated (Figure) . Similar trend was observed for stent expansion defined by MSA (p ¼ 0.16).
Conclusions: Stent expansion of the 2nd generation DESs may be predicted by the amount of target lesion calcification assessed by OCT.
TCT-563
Fusion of intravascular ultrasound and X-ray angiography does not allow accurate evaluation of the endothelial shear stress patterns and neointimal distribution after bioresorbable scaffold implantation. A comparison with optical coherence tomography-derived reconstructions 
Fanis Kalatzis
Background: To examine the endothelial shear stress (ESS) patterns, the neointimal distribution and the relation between ESS and neointimal thickness (NT) in models derived from the integration of frequency domain optical coherence tomographic (FD-OCT) and coronary angiographic data and compare these estimations with those computed in the traditional reconstructions obtained by the fusion of intravascular ultrasound (IVUS) and coronary angiography. Methods: Six segments implanted with an Absorb Bioresorbable Vascular Scaffold (Absorb BVS) that were investigated with FD-OCT and IVUS examination at baseline and 6 or 12 months follow-up were included. The IVUS and OCT data acquired at follow-up were fused separately with the angiographic data to reconstruct the luminal surface at baseline and follow-up. Blood flow simulation was performed on the baseline IVUS-based and OCT-based models and computational fluid dynamics techniques were implemented to assess the ESS and the association between the ESS and the measured NT at follow-up. Results: The IVUS-based models appeared to underestimate the neointima tissue (0.67AE0.59 mm3 vs. 15.14AE5.63 mm3, P¼0.001) compared to the FD-OCT-based reconstructions. Flow recirculation zones were detected in the FD-OCT-based reconstructions and the ESS values were lower compared to the IVUS-based models (1.29AE0.66 Pa vs. 1.87AE0.66 Pa, P¼0.030). These differences should be attributed to the poor resolution of IVUS that did not allow visualization of the protruded struts. A statistically significant inverse correlation was noted between the logarithmic ESS at baseline and the NT at follow-up in all the FD-OCT-based models which was higher than the correlation reported in 5 of the 6 IVUS-derived models (mean correlation coefficient: -0.52AE0.19 vs. -0.10AE0.04, P¼0.028).
Conclusions: It appears that the models derived by the fusion of IVUS and coronary angiography cannot provide enough detail and are incapable of assessing the microenvironment and its effect on neointima formation following an Absorb BVS implantation. FD-OCT reconstruction appears superior to IVUS-based reconstructions and it should be preferred for studying the effect of ESS on neointimal proliferation. 
